Dr Vibeke Catts
Manager
2006聽聽 聽Doctor of Philosophy (Biomedical Science), University of Queensland. Thesis title: Cell death and proliferation in mental disorder.
1999聽聽 聽Bachelor of Science with Honours, Class I (Biochemistry and Molecular Genetics), University of New South Wales. Thesis title: Elucidation of glucocorticoid resistance mechanisms in childhood acute lymphoblastic leukaemia.
Medicine & Health
Centre for Healthy Brain Ageing
Dr Vibeke Catts is the Research Manager the Centre for Healthy Brain Ageing (CHeBA), 黑料网大事记 Sydney. In this role she supports the Co-Directors and CHeBA researchers to perform their research effectively, with a particular emphasis on聽research governance and liaison with relevant regulatory bodies. Dr Catts manages the CHeBA Research Bank, facilitating the sharing of data collected as part of the Memory and Ageing Study (MAS), the Sydney Centenarian Study (SCS) and the Older Australian Twins Study (OATS) - all longitudinal studies of ageing with assessments across聽multiple research domains: neuropsychological assessment of cognitive function, questionnaires detailing lifestyle, physical and mental health of self and family, blood biochemistry and genetics, and neuroimaging including聽MRI and PET聽scans. Prior to taking up her position at the CHeBA Research Manager, Dr Catts was the study coordinator for OATS, a longitudinal twin study aiming聽to determine the genetic and environmental influences on the ageing process, and the extent to which these determinants interact.聽聽
E-mail
Location
Centre for Healthy Brain Ageing (CHeBA)
黑料网大事记 Medicine, Discipline of Psychiatry & Mental Health
Level 1, AGSM (G27)
Gate 11, Botany Street
黑料网大事记 SYDNEY NSW 2052 AUSTRALIA
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
University of New South Wales Gold Star (2014) Is the blood brain barrier compromised in schizophrenia. $40,000. with C Shannon Weickert, M Webster, S Fillman, TW Weickert.
Schizophrenia Research Institute (2013) Neurobiology of cortical thinning in schizophrenia. $16,100. with C Shannon Weickert, Y Zhang, K Newell & N Matosin.
黑料网大事记 Major Research Equipment & Infrastructure Scheme (2012) xCELLigence DP Real Time Cell Analysis (RTCA) System. $65,000. with J Fullerton, K Sidhu & C Shannon Weickert.
Cure Cancer Australia (2011) The anti-cancer effects of cholesterol trafficking and synthesis inhibitors as co-drugs in an in vivo glioblastoma multiforme model. AU$90,000. with LH Lutze-Mann, M Morris, E Hovey & M Lavin.
The Stanley Medical Research Institute (2009-2011). FAS-cinating changes in a death receptor pathway in schizophrenia. US$140,607. with C Shannon Weickert.
Rebecca L. Cooper Medical Research Foundation (2006). Establishment of the Neuroplasticity Facility for Psychotic Disorders, Royal Brisbane and Women鈥檚 Hospital. $18,000. with SV Catts & GN Elston.
Rebecca L. Cooper Medical Research Foundation (2003) Morphological studies of post-mortem brain tissue in schizophrenia. $14,150. with SV Catts, KD Bedi & GN Elston.
Rebecca L. Cooper Medical Research Foundation (2002) A functional genomics centre for psychotic disorders. $14,203. with LH Lutze-Mann & SV Catts.
Rebecca L. Cooper Medical Research Foundation (2001) Molecular genetic investigations of the causes of schizophrenia. $15,000. with LH Lutze-Mann & SV Catts.
2013聽聽 聽Participant of the 2013 Theo Murphy High Flyers Think Tank 鈥淚nspiring smarter brain research in Australia鈥, hosted by the Australian Academy of Science, Melbourne
2011聽聽 聽Dean鈥檚 Rising Star Award, Faculty of Medicine, University of New South Wales
2007聽聽 聽Young Investigator Award, International Congress on Schizophrenia Research
2001 聽 聽Australian Postgraduate Award
As the CHeBA ResearchManager, I support the Co-Directors and Centre for Healthy Brain Ageing (CHeBA) researchers to perform their research effectively, with a particular emphasis on聽research governance and liaison with relevant regulatory bodies. I also manage data sharing via the CHeBA Research Bank.
As part of my work with the Older Australian Twins Study (OATS), I provided support to investigators, staff and students, to facilitate their research. Two Independent Learning Project students under my supervision investigated longitudinal changes in cognitive function and exploring the factors that contribute to cognitive decline in older age.
Prior to joining CHeBA, I聽held a Post-Doctoral appointment at Neuroscience Research Australia, where I聽researched molecular and cellular pathology in blood and postmortem brain tissue聽from individuals with schizophrenia. During my post-doc in the Schizophrenia Research Laboratory, I聽supervised four higher degree students.聽
In collaboration with Professor Lutze-Mann, School of Biotechnology and Biomolecular Sciences, 黑料网大事记, I led an investigation of antipsychotic drugs as potential treatments for glioblastoma using cell cultures and a rodent brain tumour model. The work was supported by聽a grant by聽Cure Cancer Australia and the work of聽two PhD candidates.